These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23683462)

  • 1. Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3.
    Junttila IS; Watson C; Kummola L; Chen X; Hu-Li J; Guo L; Yagi R; Paul WE
    J Allergy Clin Immunol; 2013 Sep; 132(3):704-712.e10. PubMed ID: 23683462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of stem cell factor on the ultrastructure of Fc epsilon RI+ cells developing in IL-3-dependent murine bone marrow-derived cell cultures.
    Rottem M; Goff JP; Albert JP; Metcalfe DD
    J Immunol; 1993 Nov; 151(9):4950-63. PubMed ID: 7691960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils.
    Seder RA; Paul WE; Ben-Sasson SZ; LeGros GS; Kagey-Sobotka A; Finkelman FD; Pierce JH; Plaut M
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):137-40. PubMed ID: 1834578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis.
    Yeatman CF; Jacobs-Helber SM; Mirmonsef P; Gillespie SR; Bouton LA; Collins HA; Sawyer ST; Shelburne CP; Ryan JJ
    J Exp Med; 2000 Oct; 192(8):1093-103. PubMed ID: 11034599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Th2-dominant milieu on allergic responses in Der f 1-activated mouse basophils and mast cells.
    Yi MH; Kim HP; Jeong KY; Kim JY; Lee IY; Yong TS
    Sci Rep; 2018 May; 8(1):7706. PubMed ID: 29769546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils.
    Sumbayev VV; Yasinska I; Oniku AE; Streatfield CL; Gibbs BF
    PLoS One; 2012; 7(3):e34259. PubMed ID: 22470546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.
    Yoshimoto T; Tsutsui H; Tominaga K; Hoshino K; Okamura H; Akira S; Paul WE; Nakanishi K
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13962-6. PubMed ID: 10570181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response.
    Kawauchi T; Ishimaru K; Nakamura Y; Nakano N; Hara M; Ogawa H; Okumura K; Shibata S; Nakao A
    Allergol Int; 2017 Jul; 66(3):472-478. PubMed ID: 28259547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
    Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
    Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation.
    Chhiba KD; Hsu CL; Berdnikovs S; Bryce PJ
    J Immunol; 2017 Jun; 198(12):4868-4878. PubMed ID: 28476932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro.
    Dvorak AM; Seder RA; Paul WE; Morgan ES; Galli SJ
    Am J Pathol; 1994 Jan; 144(1):160-70. PubMed ID: 7507298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of IL-18 in basophils and mast cells.
    Yoshimoto T; Nakanishi K
    Allergol Int; 2006 Jun; 55(2):105-13. PubMed ID: 17075246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat5: an essential regulator of mast cell biology.
    Shelburne CP; McCoy ME; Piekorz R; Sexl VV; Gillespie SR; Bailey DP; Gharse A; Mirmonsef P; Mann MN; Kashyap M; Wright HV; Chong HJ; Bouton LA; Ramirez CD; Lantz CS; Ryan JJ
    Mol Immunol; 2002 Sep; 38(16-18):1187-91. PubMed ID: 12217382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The
    Abdul Qayum A; Koh B; Martin RK; Kenworthy BT; Kharwadkar R; Fu Y; Wu W; Conrad DH; Kaplan MH
    J Immunol; 2019 Sep; 203(5):1111-1121. PubMed ID: 31350354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.
    Drube S; Heink S; Walter S; Löhn T; Grusser M; Gerbaulet A; Berod L; Schons J; Dudeck A; Freitag J; Grotha S; Reich D; Rudeschko O; Norgauer J; Hartmann K; Roers A; Kamradt T
    Blood; 2010 May; 115(19):3899-906. PubMed ID: 20200353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis.
    Nakajima S; Ishimaru K; Kobayashi A; Yu G; Nakamura Y; Oh-Oka K; Suzuki-Inoue K; Kono K; Nakao A
    Sci Rep; 2019 Dec; 9(1):18423. PubMed ID: 31804564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHIP represses Th2 skewing by inhibiting IL-4 production from basophils.
    Kuroda E; Antignano F; Ho VW; Hughes MR; Ruschmann J; Lam V; Kawakami T; Kerr WG; McNagny KM; Sly LM; Krystal G
    J Immunol; 2011 Jan; 186(1):323-32. PubMed ID: 21131429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-induced cytokine production by conventional and innate lymphoid cells.
    Guo L; Junttila IS; Paul WE
    Trends Immunol; 2012 Dec; 33(12):598-606. PubMed ID: 22959641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
    Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
    Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation.
    Yanagihara Y; Kajiwara K; Basaki Y; Ikizawa K; Ebisawa M; Ra C; Tachimoto H; Saito H
    Clin Exp Immunol; 1998 Jan; 111(1):136-43. PubMed ID: 9472673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.